Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus

Abstract Background Nonconvulsive status epilepticus (NCSE) is a diagnosis that is often challenging and one that may progress to refractory NCSE. Ketamine is a noncompetitive N-methyl-d-aspartate antagonist that increasingly has been used to treat refractory status epilepticus. Current Neurocritica...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michael A. Pizzi, Prasuna Kamireddi, William O. Tatum, Jerry J. Shih, Daniel A. Jackson, William D. Freeman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-08-01
coleção:	Journal of Intensive Care
Assuntos:	Enteral ketamine Intravenous ketamine Nonconvulsive status epilepticus Refractory status epilepticus Seizures
Acesso em linha:	http://link.springer.com/article/10.1186/s40560-017-0248-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!